News & Alerts
-
Dec- 2023 -11 December
Shuttle Pharma Submits Ropidoxuridine IND for Glioblastoma Treatment to FDA
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”) has announced a significant stride in its mission to address glioblastoma, a…
Read More » -
11 December
Global H1N1 Vaccines Market Thrives: Intramuscular Segment and Hospital Pharmacies at the Forefront
A recent report by Research and Markets forecasts significant growth in the Global H1N1 Vaccines Market until 2028. This comprehensive…
Read More » -
11 December
Novartis Reports Positive 48-Week Results for Fabhalta in PNH Trial
Novartis Pharmaceuticals Corporation has released new 48-week results from the Phase III APPLY-PNH trial, showcasing sustained efficacy and long-term safety…
Read More » -
11 December
Hoba Therapeutics Raises EUR 23 Million in Series A Financing for Innovative Neuropathic Pain Treatment
Danish biotech company, Hoba Therapeutics, has successfully secured EUR 23 million (USD 25 million) in a Series A financing first…
Read More » -
11 December
Medtronic and Cosmo Pharmaceuticals Propel Healthcare Forward with AI-Driven Care Collaboration
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, has announced a definitive agreement to expand its partnership with…
Read More » -
9 December
FDA Approves Revolutionary Gene Therapies, Offering Lifelong Relief for Sickle Cell Disease
In a groundbreaking move, the U.S. Food and Drug Administration (FDA) granted approval on Friday to two gene therapies for…
Read More » -
9 December
FDA Approves Expanded Use of CRESEMBA® (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of CRESEMBA® (isavuconazonium sulfate), an azole…
Read More » -
9 December
Global Premature Ejaculation Therapeutics Market Expected to Reach $4,062.34 Million by 2029, Growing at a CAGR of 8.74%
The “Global Premature Ejaculation Therapeutics Market – Focused Insights 2024-2029” report, recently added to ResearchAndMarkets, projects significant growth in the…
Read More » -
9 December
Active Pharmaceutical Ingredients Market Projected to Surpass $372.4 Billion by 2030 at 6.8% CAGR, Reports Coherent Market Insights
The global Active Pharmaceutical Ingredients (API) market, valued at US$ 235 Billion in 2023, is anticipated to reach US$ 372.4…
Read More » -
8 December
NIH Clinical Trial of Tuberculous Meningitis Drug Regimen Begins
Six-month multidrug regimen being evaluated against standard treatment. What A trial of a new drug regimen to treat tuberculous meningitis…
Read More »